Genetic Testing for Chronic Kidney Diseases: Clinical Utility and Barriers Perceived by Nephrologists.

ABSTRACT:

Rationale & objective

The identification of pathogenic variants in genes associated with chronic kidney disease can provide patients and nephrologists with actionable information to guide diagnoses and therapeutic plans. However, many nephrologists do not use genetic testing despite costs decreasing over time and more widespread availability.

Study design

We conducted a survey to uncover the perceptions of general adult nephrologists about the utility of and barriers to genetic testing in clinical practice.

Setting & participants

The online survey was administered to board-certified nephrologists (n = 10,054) in the United States.

Analytical approach

We analyzed demographic characteristics of the survey respondents and their responses in the context of their us

SUBMITTER: Mrug M 

PROVIDER: S-EPMC8664736 | biostudies-literature | 2021 Nov-Dec

REPOSITORIES: biostudies-literature